Type 2 Diabetes (original) (raw)
Latest News for: type 2 diabetes
Syntax Bio Announces Collaboration with Mayo Clinic to Advance Pancreatic Cell Therapy for Type 1 Diabetes
The Joplin Globe 09 Jun 2026
CHICAGO--(BUSINESS WIRE)--Jun 9, 2026-- ... .
Ercros supports the Valenta Sugar Cup in aid of type 1 diabetes research (Ercros SA)
Public Technologies 09 Jun 2026
With this collaboration, Ercros participates for the third consecutive year in this initiative and contributes to promoting type 1 diabetes research and raising awareness in society about the impact of this disease.
Novo Nordisk introduces updated Rybelsus® tablet formulation in Canada for adults living with type 2 diabetes
Canada Newswire 09 Jun 2026
Rybelsus® (semaglutide tablets) is the first and only GLP-1 tablet approved in Canada for adults with type 2 diabetes.1 The updated formulation offers the same established clinical profile at lower ...
Alexander Zverev triumphs at Roland Garros despite Type 1 Diabetes
Gulf News 08 Jun 2026
... was up against two opponents, Italian Flavio Cobolli and Type 1 Diabetes.
Living With Type 1 Diabetes Since Age 4, Alexander Zverev Wins First Grand Slam At 29
News18 08 Jun 2026
The French Open champion has spent 25 years managing Type 1 diabetes, proving the condition does not have to limit ambition ....
CrowdHealth Unveils Bold New Program to Reverse Type 2 Diabetes
PR Newswire 08 Jun 2026
AUSTIN, Texas, June 8, 2026 /PRNewswire/ -- CrowdHealth today announced the launch of a revolutionary new program aimed at helping participants reverse Type 2 Diabetes.
New study shows promising functional cure for Type 1 diabetes
WPXI 08 Jun 2026
It’s a development millions of people living with Type 1 diabetes never thought would happen ... Type 1 diabetes is an autoimmune condition where the body’s immune system destroys the insulin-producing cells in the pancreas.
Broken bones and Type 1 diabetes: How Zverev broke every 'Major' barrier
Khaleejtimes 08 Jun 2026
And to achieve all of this while living with diabetes — that should hardly be possible ... Born to Russian immigrants in Germany, Zverev has battled Type 1 diabetes since the age of four ... with diabetes.
Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials
PR Newswire 08 Jun 2026
Lilly plans to submit Foundayo for type 2 diabetes to the U.S ... These results support a potential shift toward using oral GLP-1 receptor agonist therapies like orforglipron earlier as a foundation of type 2 diabetes care.".
Insulin inhaler could become alternative for Type 1 diabetes insulin injections
CBS News 07 Jun 2026
A medical breakthrough is showing promise for millions of Americans with Type 1 diabetes. It's an alternative to taking insulin without the injections. Mark Strassmann has more details ... .
People with type 2 diabetes who were increased to semaglutide 2 mg were as likely ...
The St Marys Daily Press 07 Jun 2026
Adults with type 2 diabetes on semaglutide 1 mg whose dose was increased to 2 mg were as likely to reach an HbA1c level <7% and were more likely to see weight loss of ≥5% vs those who were switched ....
82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with ...
Ouachita Citizen 07 Jun 2026
New Study Highlights Potential of CGM to Help Patients Improve Diabetes Management in Primary Care Settings ... .
Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
Ouachita Citizen 07 Jun 2026
Findings highlight use of once-weekly injection to expand potential options for weight reduction, A1C control, knee osteoarthritis, and obstructive sleep apnea ... .
First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood ...
Fremont Tribune 06 Jun 2026
Phase 2 Study Results Highlight Use of Once-Daily Injection for Weight Loss and Reduction in Insulin Use ... .
Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
Fremont Tribune 06 Jun 2026
Study of Over Three Million Patients for Risk of Type 2 Diabetes Demonstrates Potential for More Advanced Approach to Early Identification ... .